摘要
新型冠状病毒肺炎(COVID-19)给我国乃至世界带来巨大的公共卫生问题。目前尚无针对于COVID-19的特效药。急性呼吸窘迫综合征是COVID-19患者的常见致命性并发症之一,与其较高的重症率和病死率相关。本文结合相关文献、近期临床观察以及既往经验,对COVID-19合并急性呼吸窘迫综合征的关联进行解读,并对其治疗和管理进行探索性综述,以期为临床治疗提供参考。
The outbreak of COVID-19 has brought huge public health problems to China and even the world.Currently,there is no certain cure medication for COVID-19.Acute respiratory distress syndrome(ARDS)is one of the most common fatal complications of COVID-19,which is associated with the high risk of severity and mortality.Based on the relevant literature,recent clinical observations and experiences of ARDS in COVID-19,this article aim to discuss the clinical relevance between COVID-19 and ARDS,with the hope of improving the treatment and management of ARDS in COVID-19 patients.
作者
李芯雨
陈中琦
吉宁飞
张明顺
Li Xinyu;Chen Zhongqi;Ji Ningfei;Zhang Mingshun(NHC Key Laboratory of Antibody Technique,Department of Immunology,Nanjing Medical University,Nanjing 211166,China;Department of Respiratory and Critical Care Medicine,the First Affiliated Hospital of Nanjing Medical University,Nanjing 210029,China)
出处
《国际呼吸杂志》
2020年第22期1690-1696,共7页
International Journal of Respiration
基金
国家自然科学基金(81671563)
江苏省重点研发项目(BE2020616)。
